BVF II GP LLC
CIK 1803806 · last filed 2026-07-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$91.49M
Companies
8
Total Filings
11
Lifetime Open-Market Net
-$2.54B
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XOMA | 10%+ Owner | 0 | $40.17 | $0 | $1.42M | 2 | 2026-07-16 |
| KYMR | Director | 484,057 | $109.62 | $53.06M | $0 | 1 | 2026-06-25 |
| XOMAP | Director | 0 | $24.98 | $0 | -$159.93M | 2 | 2025-01-28 |
| OLMA | Director | 3,684,068 | $10.43 | $38.42M | $0 | 1 | 2024-06-18 |
| RAIN | Director | 0 | $1.11 | $0 | $0 | 1 | 2024-01-29 |
| POINT Biopharma Global Inc. (PNT) Delisted | 0 | $12.50 | $0 | -$2.14B | 1 | 2023-12-20 | |
| CTI BIOPHARMA CORP (CTIC) Delisted | Director | 2,228,652 | $9.09 | $20.26M | $0 | 2 | 2023-04-07 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | 5,663,912 | $0.04 | $253.2K | -$242.06M | 1 | 2021-01-26 |
Recent Filings · Page 2 of 2
11 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-04 | CTI BIOPHARMA CORP (CTIC) Delisted | Mixed | — | $0 | EDGAR |
Showing 11–11 of 11
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.